CoChat

5‐Hydroxytryptamine Medications for the Treatment of Obesity

Burke, L. K., Heisler, L. K. · 2015 · Journal of Neuroendocrinology
Cited by 80

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

The central 5‐hydroxytryptamine (5‐HT; serotonin) system represents a fundamental component of the brain's control of energy homeostasis. Medications targeting the 5‐HT pathway have been at the forefront of obesity treatment for the past 15 years. Pharmacological agents targeting 5‐HT receptors (5‐HTR), in combination with genetic models of 5‐HTR manipulation, have uncovered a role for specific 5‐HTR s in energy balance and reveal the 5‐HT2C R as the principal 5‐HTR mediating this homeostatic process. Capitalising on this neurophysiological machinery, 5‐HT2C R agonists improve obesity and glycaemic control in patient populations. The underlying therapeutic mechanism has been probed using model systems and appears to be achieved primarily through 5‐HT2C R modulation of the brain melanocortin circuit via activation of pro‐opiomelanocortin neurones signalling at melanocortin4 receptors. Thus, 5‐HT2C R agonists offer a means to improve obesity and type 2 diabetes, which are conditions that now represent global challenges to human health.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jne.12287

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 80

Metadata

Authors
Burke, L. K., & Heisler, L. K.
Venue
Journal of Neuroendocrinology
Publisher
Wiley
Published
2015-05-26
Volume
27
Issue
6
Pages
389-398
ISSN
  • 0953-8194 (ISSN-L)
  • 1365-2826
OpenAlex
W1505713219
Cited by
80
References
16
FWCI
4.46
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.